FSDDF News and Press, FSD Pharma Inc - Class B From 01/17/20

FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020 Canada NewsWire TORONTO, Jan. 17, 2020 TORONTO , Jan. 17, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company") is pleased to announ...

- Management to Present at Biotech Showcase 2020 - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the "Company") announced that its Class B Subordinate Voting Shares (the “Shares”) will commence trading on the Nasdaq Capital Market ...

- Management to Present at Biotech Showcase 2020 - Insert in second paragraph, first sentence of release: Executive Co-Chairman and CEO. The corrected release reads: FSD PHARMA TO COMMENCE TRADING ON NASDAQ CAPITAL MARKET UNDER SYMBOL ‘HUGE’ - Management t...

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020 Canada NewsWire TORONTO, Jan. 6, 2020 TORONTO , Jan. 6, 2020 /CNW/ -  FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company") today announce...

FSD Pharma ( OTCQB:FSDDF ) announces three key executive appointments: More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...

FSD Pharma Strengthens Management Team Canada NewsWire TORONTO, Jan. 2, 2020 - Donal Carroll Appointed Chief Financial Officer, Dr. Sandra Lottes as Vice President and Head of Clinical Research at BioSciences Division, and Shahzad Shah as Chief Operating Officer at FV P...

The Nasdaq has approved FSD Pharma's ( OTCQB:FSDDF ) application to have its Class B Subordinate Voting Shares listed on the Nasdaq. More news on: FSD Pharma Inc., Healthcare stocks news, Read more ...

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the "Company") announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares (the “Shares”) listed on the Nasdaq Capital Market (“Nasdaq”). FSD...

FSD Pharma Receives Approval to List its Shares on Nasdaq Canada NewsWire TORONTO, Dec. 16, 2019 TORONTO , Dec. 16, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company") announces that Nasdaq has approved its application to h...

FSD Pharma to Present at Investor Summit on December 17 Canada NewsWire TORONTO, Dec. 13, 2019 TORONTO , Dec. 13, 2019 /CNW/ -  FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9)  ("FSD Pharma" or the "Company") announces that Raza Bokhari , MD, Executive Co...